KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Current Leases (2019 - 2025)

Edwards Lifesciences has reported Current Leases over the past 8 years, most recently at $24.5 million for Q4 2025.

  • Quarterly results put Current Leases at $24.5 million for Q4 2025, up 4.7% from a year ago — trailing twelve months through Dec 2025 was $24.5 million (up 4.7% YoY), and the annual figure for FY2025 was $24.5 million, up 4.7%.
  • Current Leases for Q4 2025 was $24.5 million at Edwards Lifesciences, down from $26.8 million in the prior quarter.
  • Over the last five years, Current Leases for EW hit a ceiling of $26.8 million in Q3 2025 and a floor of $21.5 million in Q2 2024.
  • Median Current Leases over the past 5 years was $24.3 million (2023), compared with a mean of $24.4 million.
  • Biggest five-year swings in Current Leases: fell 11.52% in 2024 and later rose 20.47% in 2025.
  • Edwards Lifesciences' Current Leases stood at $25.5 million in 2021, then changed by 0.0% to $25.5 million in 2022, then fell by 10.2% to $22.9 million in 2023, then increased by 2.18% to $23.4 million in 2024, then rose by 4.7% to $24.5 million in 2025.
  • The last three reported values for Current Leases were $24.5 million (Q4 2025), $26.8 million (Q3 2025), and $25.9 million (Q2 2025) per Business Quant data.